IsoBio
Gladwyne, US · Founded 2025 · Delaware corporation
Find your way into IsoBio
Sign up to see every warm intro you have to IsoBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the IsoBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BB
Bruce B. TurnerNamed on SEC filing
Board
TW
Todd WiderMr. Wider is the Director of the Issuer.
PM
Paul MannBoard director
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 round · 2025
▶$1.7MraisedNov 2025 · 2 investors · Other Health CareRule 506(b)
▶$1.7MraisedNov 2025 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Todd WiderDirector, Executive Officer, Promoter
- Paul MannDirector
- Bruce B. TurnerDirector, Executive Officer, Promoter
- Offering amount
- $3M
- Amount sold
- $1.7M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has IsoBio raised?
- IsoBio has disclosed $1.7M raised across 1 round.
- Where is IsoBio headquartered?
- IsoBio is headquartered in Gladwyne, US.